Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
Argus Health
Julphar
Boehringer Ingelheim
Covington
Colorcon
Accenture
Daiichi Sankyo
Cipla

Generated: May 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,599,530

« Back to Dashboard

Which drugs does patent 6,599,530 protect, and when does it expire?

Patent 6,599,530 protects COMTAN and is included in one NDA.

This patent has forty-five patent family members in thirty-seven countries.
Summary for Patent: 6,599,530
Title: Oral compacted composition comprising catechol derivatives
Abstract:The present invention relates to an oral compacted composition comprising entacapone, nitecapone, or a pharmaceutically acceptable salt thereof and croscarmellose sodium. The composition is premised on the discovery that croscarmellose sodium increases the release rate of entacapone or nitecapone from an oral compacted composition. Preferably the amount of croscarmellose sodium in the composition is at least 6% by weight, preferably from about 8% to about 16% by weight, especially from about 10% to about 14% by weight.
Inventor(s): Vahervuo; Kari (Espoo, FI)
Assignee: Orion Corporation (Espoo, FI)
Application Number:09/152,263
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,599,530
Patent Claim Types:
see list of patent claims
Composition; Dosage form; Formulation; Process; Use;

Drugs Protected by US Patent 6,599,530

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Orion Pharma COMTAN entacapone TABLET;ORAL 020796-001 Oct 19, 1999 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y TREATMENT OF PARKINSON'S DISEASE ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 6,599,530

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 021806 ➤ Try a Free Trial
Austria 256454 ➤ Try a Free Trial
Australia 5748299 ➤ Try a Free Trial
Australia 746889 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Daiichi Sankyo
Cipla
Cerilliant
Argus Health
Mallinckrodt
McKinsey
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.